跳至主要内容
临床试验/NCT06130137
NCT06130137尚未招募不适用

Genome-based Multiomics Analysis on Gut Microbiome in People Living With HIV and HBV

Kangbuk Samsung Hospital0 个研究点目标入组 200 人开始时间: 2023年11月27日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
200
主要终点
Collect clinical information data and stool from HIV and HBV patients

研究概览

简要总结

Building a Microbiome Data Platform and Conducting Clinical Evidence Research in Individuals Infected with the Human Immunodeficiency Virus (HIV) and Hepatitis B virus.

详细描述

Chronic HIV infection, which often results in metabolic disorders, leads to shifts in the gut microbiota, contributing to immune activation and chronic inflammation. This study seeks to compare the gut microbiota in individuals with chronic HIV infection and chronic hepatitis B patients. The objective is to identify specific gut bacterial strains and metabolic pathways linked to the metabolic disorders commonly observed in HIV patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HIV patients
  • Inidividuals over 19 years old
  • HIV patients on antiretroviral therapy (ART)
  • HBV patients
  • Individuals over 19 years old
  • Chronic hepatitis B patients with either chronic hepatitis, liver cirrhosis or hepatocellular carcinoma

排除标准

  • Patients with indeterminate colitis
  • Individuals who have used antibiotics or steroids within 24 hours of the microbiome sample collection (excluding antiviral treatments for hepatitis B and HIV)
  • Individuals who have used vaginal or external medications, including antifungal agents, within 24 hours of microbiome sample collection
  • Those with acute illnesses, with or without fever, of moderate or severe severity; however, sampling may be postponed until the subject recovers.
  • Individuals with gastrointestinal disorders that may impact microbiome analysis and are currently medically uncontrolled or under treatment for the respective condition
  • Individuals with a positive result in a urine pregnancy test, pregnant, or breastfeeding at the time of microbiome sample collection
  • Individuals for whom medical opinions suspect that they may have an impact on the sample collection at the time of microbiome collection.

结局指标

主要结局

Collect clinical information data and stool from HIV and HBV patients

时间窗: 2 years

Clinical information data will be collected from both HIV and HBV infected patients. Biosamples collected from these individuals will be used to establish a multi-omics analysis platform, including the examination of the intestinal microbiome. With this platform, comparative clinical studies will be conducted to uncover the disease's pathophysiology and identify potential biomarkers related to metabolic diseases.

次要结局

  • Shotgun metagenomic sequencing will be done with stool collected from HIV and HBV patients(2 years)

研究者

发起方
Kangbuk Samsung Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Eun-Jeong Joo

M.D, Ph.D

Kangbuk Samsung Hospital

相似试验